Cointime

Download App
iOS & Android

NGM Biopharmaceuticals

company
Funding Round
Series E
Money Raised
$ 105.99M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
Merck - Yes - Detail